投资人PDS规划公司和签名的LLC增加了他们在主要制药商Takeda制药公司持有的股份。 Investors PDS Planning Inc and Signaturefd LLC have boosted their holdings in Takeda Pharmaceutical, a major drugmaker.

PDS规划公司和签名有限公司增加了对Takeda制药有限公司的股份,该公司是一家专门从事肿瘤学和胃肠病等领域的全球制药公司。 PDS Planning Inc and Signaturefd LLC have increased their stakes in Takeda Pharmaceutical Company Limited, a global pharmaceutical company specializing in areas like oncology and gastroenterology. Takeda的股票价格是15.14美元,市场上限为481.6亿美元,P/E比率为37.84。 Takeda's stock price is $15.14, with a market cap of $48.16 billion and a P/E ratio of 37.84. 最近一个季度的每股收入为0.42美元,比预期的多0.8美元。 Earnings per share for the latest quarter were $0.42, exceeding expectations by $0.08. 分析员预测今年每股收入为1.64。 Analysts predict 1.64 earnings per share for this year.